Mohamed El Farissi1, MD; Daniëlle C.J. Keulards1, MD; Marcel van 't Veer1, MSc, PhD; Jo M. Zelis1, MD; Colin Berry2, MD, PhD; Bernard De Bruyne3, MD, PhD; Thomas Engstrøm4, MD, PhD; Ole Fröbert5, MD, PhD; Zsolt Piroth6, MD, PhD; Keith G. Oldroyd2, MD, PhD; Pim A.L. Tonino1, MD, PhD; Nico H.J. Pijls1, MD, PhD; Luuk C. Otterspoor1, MD, PhD
1. Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands; 2. Department of Cardiology, Golden Jubilee National Hospital, Glasgow, United Kingdom; 3. Cardiovascular Center, OLV Clinic, Aalst, Belgium; 4. Department of Cardiology, Rigshospitalet, Copenhagen, Denmark; 5. Department of Cardiology, Faculty of Health, Örebro University, Örebro, Sweden; 6. Department of Adult Cardiology, Hungarian Institute of Cardiology, Budapest, Hungary
In ST-elevation myocardial infarction (STEMI), early restoration of blood flow, preferably by primary percutaneous coronary intervention (PPCI), is paramount to limit infarct size (IS) and improve long-term outcomes1. However, reperfusion by itself may also cause damage to the myocardium and increase IS. This has been termed myocardial reperfusion injury2.
In animal models of acute myocardial infarction, it has been demonstrated that hypothermia decreases IS3. In contrast, human studies applying systemic cooling methods have not yet been able to confirm this protective effect. Recently, we developed a new method to provide selective intracoronary hypothermia during PPCI4. The ...
No account yet? Create my pcr account
Sign up for free!
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases
Coronary interventionsSTEMIStents and scaffoldsOther coronary interventions
Read next article
Clinical impact of intervention strategies after failed transcatheter mitral valve repair